A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests – Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris – can help doctors make better decisions about how to treat patients with early stage prostate cancer.
Strategic agreement signed for distribution of Yimmugo® in the United States based on the framework established in July – Biotech Investments
EQS-News: Biotest AG / Key word(s): Market Launch Strategic agreement signed for distribution of Yimmugo® in the United States based on the framework established in